Neurocrine Biosciences, Inc (NASDAQ:NBIX) shares traded -0.22% lower at $129.11 on Wall Street last session.
NBIX stock price is now 7.05% away from the 50-day moving average and 6.21% away from the 200-day moving average. The market capitalization of the company currently stands at $12.78B.
With the price target maintained at $138, Needham recently Upgraded its rating from Hold to Buy for Neurocrine Biosciences, Inc (NASDAQ: NBIX). On April 14, 2025, RBC Capital Mkts Upgraded its previous ‘Sector Perform’ rating to ‘Outperform’ on the stock keeping its target price maintained at $137, while ‘Deutsche Bank’ rates the stock as ‘Hold’
In other news, JUDE ONYIA, Officer bought 80,181 shares of the company’s stock on Jul 02 ’25. The stock was bought for $10,263,168 at an average price of $128.00. An SEC document containing details of the transaction can be found on the SEC’s website. On May 27 ’25, Director GORMAN KEVIN CHARLES sold 9,613 shares of the business’s stock. A total of $1,157,211 was realized by selling the stock at an average price of $120.38. This leaves the insider owning 514,596 shares of the company worth $66.44 million. A total of 3.53% of the company’s stock is owned by insiders.
During the past 12 months, Neurocrine Biosciences, Inc has had a low of $84.23 and a high of $157.98. As of last week, the company has a debt-to-equity ratio of 0.19, a current ratio of 3.13, and a quick ratio of 3.02. According to the stock market information, the enterprise value for the company is $11988614144, which is based on a 43.78 price-to-earnings ratio, a 1.26 price-to-earnings-growth ratio, and a beta of 0.25. The fifty day moving average price for NBIX is $120.6044 and a two-hundred day moving average price translates $121.5579 for the stock.
The latest earnings results from Neurocrine Biosciences, Inc (NASDAQ: NBIX) was released for 2025-03-31. The net profit margin was 12.68% and return on equity was 12.43% for NBIX. The company reported revenue of $572.6 million for the quarter, compared to $515.3 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 11.12 percent.
